![Thomas Casdagli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Casdagli
Director/Board Member at
MVM Scotland (No. 3) GP Ltd.
Profile
Thomas Theodore Casdagli is currently a Director at Xention Pharma Ltd., eZono AG, MVM Executive Ltd., MVM (CIP) (No.3) Ltd., MVM (CIP) (No.2) Ltd., MVM (GP) Ltd., MVM (GP) (No.
2) Ltd., and Dassiet Oy.
He is also a Partner at MVM Partners LLP.
In the past, he served as Chairman at Patient Connect Ltd., Non-Executive Director at Lombard Medical Technologies Ltd., Alliance Pharma Plc, Avantium International BV, and Heptares Therapeutics Ltd. He was also a Member-Supervisory Board at Valneva SE from 2019 to 2021.
He received his undergraduate degree from the University of Oxford in 1998.
Thomas Casdagli active positions
| Companies | Position | Start |
|---|---|---|
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Private Equity Investor | 01/01/2002 |
MVM Executive Ltd. | Director/Board Member | 27/10/2010 |
MVM (CIP) (No.2) Ltd. | Director/Board Member | 27/10/2010 |
MVM (CIP) (No.3) Ltd. | Director/Board Member | 27/10/2010 |
MVM (GP) Ltd. | Director/Board Member | 27/10/2010 |
MVM (GP) (No. 2) Ltd. | Director/Board Member | 27/10/2010 |
MVM Scotland (No. 3) GP Ltd. | Director/Board Member | 27/10/2010 |
MVM Gp (No.3) Scottish LP | Director/Board Member | - |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Develops and markets products for orthopedic and traumatology use | Director/Board Member | 01/11/2014 |
| ░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of Thomas Casdagli
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░ ░░░░░░ ░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Thomas Casdagli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
76
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Lombard Medical Technologies Ltd.
 Lombard Medical Technologies Ltd. Medical SpecialtiesHealth Technology Provides cardiovascular devices and medical fabrics | Health Technology |
Alliance Pharma Plc
 Alliance Pharma Plc Pharmaceuticals: MajorHealth Technology Manufactures, develops and distributes healthcare brands and prescription medicines | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
Avantium International BV
 Avantium International BV Engineering & ConstructionIndustrial Services Provides simulation technologies in contract research and development | Industrial Services |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Nxera Pharma UK Ltd.
 Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
eZono AG
 eZono AG Medical SpecialtiesHealth Technology Develops portable ultrasound system | Health Technology |
MVM Executive Ltd. | |
MVM (CIP) (No.3) Ltd. | |
MVM (CIP) (No.2) Ltd. | |
MVM (GP) Ltd. | |
MVM (GP) (No. 2) Ltd. | |
Dassiet Oy
Dassiet Oy Medical SpecialtiesHealth Technology Develops and markets products for orthopedic and traumatology use | Health Technology |
MVM Scotland (No. 3) GP Ltd. | |
MVM Gp (No.3) Scottish LP | |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Patient Connect Ltd.
 Patient Connect Ltd. Medical/Nursing ServicesHealth Services Provides supporting services for patients at the point of dispensing | Health Services |
- Stock Market
- Insiders
- Thomas Casdagli
